{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:40:57Z","timestamp":1794850857575,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The International System for Reporting Serous Fluid Cytopathology (TIS) was recently proposed. We retrospectively applied TIS recommendations for reporting the cytological diagnosis of serous effusions and reported our experience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All the serous effusions from January 2018 to September 2021 were retrieved from the database. Recategorization was performed using the TIS classification, the risk of malignancy (ROM) was calculated for each TIS category. In addition, on the basis of the original TIS classification, we further subdivided the TIS category IV (suspicious for malignancy, SFM) into 2 groups (IVa and IVb) according to cytological characteristics (quality and quantity) to explore the necessity of SFM subclassification. The performance evaluation was carried out using different samples (pleural, peritoneal and pericardial effusions) and preparation methods (conventional smears, liquid-based preparations and cell blocks).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 3633 cases were studied: 17 (0.5%) were diagnosed as \u2018nondiagnostic\u2019 (I, ND), 1100 (30.3%) as \u2018negative for malignancy\u2019 (II, NFM), 101 (2.8%) as \u2018atypia of undetermined significance\u2019 (III, AUS), 677 (18.6%) as \u2018suspicious for malignancy\u2019 (IV, SFM), and 1738 (47.8%) as \u2018malignant\u2019 (V, MAL). The ROMs for the categories were 38.5%, 28.6%, 52.1%, 99.4% and 100%, respectively. The ROM for SFM was significantly higher than that for AUS (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), while the difference between the ROMs for IVa and IVb was insignificant. The sensitivity, negative predictive value (NPV) and diagnostic accuracy of liquid-based preparations were all superior to those of conventional smears and cell blocks in detecting abnormalities. Using the three preparation methods simultaneously had the highest sensitivity, NPV and diagnostic accuracy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serous effusion cytology has a high specificity and positive predictive value (PPV), and TIS is a user-friendly reporting system. Liquid-based preparations could improve the sensitivity of diagnosis, and it is best to use three different preparation methods simultaneously for serous effusion cytologic examination.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13000-022-01241-4","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T12:25:29Z","timestamp":1656764729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center"],"prefix":"10.1186","volume":"17","author":[{"given":"Yan-li","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-zhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-mei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"issue":"1","key":"1241_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/1759-7714.12271","volume":"7","author":"T Ebata","year":"2016","unstructured":"Ebata T, Okuma Y, Nakahara Y, Yomota M, Takagi Y, Hosomi Y, et al. Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis. Thorac Cancer. 2016;7(1):39\u201343.","journal-title":"Thorac Cancer"},{"key":"1241_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","volume":"15","author":"MM Zamboni","year":"2015","unstructured":"Zamboni MM, da Silva CT Jr., Baretta R, Cunha ET, Cardoso GP. Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med. 2015;15:29.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"1241_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","volume":"4","author":"SL Sangisetty","year":"2012","unstructured":"Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4(4):87\u201395.","journal-title":"World J Gastrointest Surg"},{"issue":"6","key":"1241_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jasc.2019.08.006","volume":"8","author":"BA Crothers","year":"2019","unstructured":"Crothers BA, Chandra A. Proceedings of the American Society of Cytopathology Companion Session at the 2019 United States and Canadian Academy of Pathology Meeting Part 1: towards an International System for Reporting Serous Fluid Cytopathology. J Am Soc Cytopathol. 2019;8(6):362\u20138.","journal-title":"J Am Soc Cytopathol"},{"key":"1241_CR5","first-page":"1","volume":"63","author":"A Chandra","year":"2019","unstructured":"Chandra A, Crothers B, Kurtycz D, Schmitt F. Announcement: The International System for Reporting Serous Fluid Cytopathology. Acta Cytol. 2019;63:1\u20133.","journal-title":"Acta Cytol"},{"issue":"1","key":"1241_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cncy.22345","volume":"129","author":"T Hou","year":"2021","unstructured":"Hou T, Landon G, Stewart J, Roy-Chowdhuri S. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions. Cancer Cytopathol. 2021;129(1):75\u201382.","journal-title":"Cancer Cytopathol"},{"key":"1241_CR7","doi-asserted-by":"crossref","unstructured":"Savari O, Jassim S, Ferrer H, Ganocy SJ, Ganesan S. Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining \u201catypical\u201d category in serous fluid cytology. Diagn Cytopathol. 2020;48(12):1199\u2013204.","DOI":"10.1002\/dc.24541"},{"issue":"5","key":"1241_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/dc.24653","volume":"49","author":"HN Gokozan","year":"2021","unstructured":"Gokozan HN, Harbhajanka A, Lyden S, Michael CW. Root cause analysis of indeterminate diagnoses in serous fluids cytopathology. Diagn Cytopathol. 2021;49(5):633\u20139.","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"1241_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000507311","volume":"64","author":"EF Rodriguez","year":"2020","unstructured":"Rodriguez EF, Jones R, Gabrielson M, Santos D, Pastorello RG, Maleki Z. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology. Acta Cytol. 2020;64(5):477\u201385.","journal-title":"Acta Cytol"},{"issue":"5","key":"1241_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/dc.24440","volume":"49","author":"C Lobo","year":"2021","unstructured":"Lobo C, Costa J, Petronilho S, Monteiro P, Le\u00e7a L, Schmitt F. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center. Diagn Cytopathol. 2021;49(5):596\u2013605.","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"1241_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/dc.24804","volume":"49","author":"Y Xu","year":"2021","unstructured":"Xu Y, Hu AY, Wang SM, Wang Q, Pan YC, Zhang SH. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology. Diagn Cytopathol. 2021;49(9):997\u20131007.","journal-title":"Diagn Cytopathol"},{"issue":"10","key":"1241_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/dc.24837","volume":"49","author":"S Jha","year":"2021","unstructured":"Jha S, Sethy M, Adhya AK. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy. Diagn Cytopathol. 2021;49(10):1089\u201398.","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"1241_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/diagnostics11061126","volume":"11","author":"D Pinto","year":"2021","unstructured":"Pinto D, Cruz E, Branco D, Linares C, Carvalho C, Silva A, et al. Cytohistological Correlation in Pleural Effusions Based on the International System for Rep. Diagnostics (Basel). 2021;11(6):1126.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"1241_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/cyt.12755","volume":"30","author":"E Valerio","year":"2019","unstructured":"Valerio E, Nunes W, Cardoso J, Santos A, Bovolim G, Domingos T, et al. A 2-year retrospective study on pleural effusions: A cancer centre experience. Cytopathol. 2019;30(6):607\u201313.","journal-title":"Cytopathol"},{"issue":"11","key":"1241_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/dc.24278","volume":"47","author":"SJ Farahani","year":"2019","unstructured":"Farahani SJ, Baloch Z. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature. Diagn Cytopathol. 2019;47(11):1145\u201359.","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"1241_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cncy.21518","volume":"123","author":"ED Rossi","year":"2015","unstructured":"Rossi ED, Bizzarro T, Schmitt F, Longatto-Filho A. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience. Cancer Cytopathol. 2015;123(4):258\u201366.","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"1241_CR17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1378\/chest.08-2002","volume":"135","author":"W Abouzgheib","year":"2009","unstructured":"Abouzgheib W, Bartter T, Dagher H, Pratter M, Klump W. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. Chest. 2009;135(4):999\u20131001.","journal-title":"Chest"},{"issue":"3","key":"1241_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2303.2010.00786.x","volume":"22","author":"SC Thomas","year":"2011","unstructured":"Thomas SC, Davidson LR, McKean ME. An investigation of adequate volume for the diagnosis of malignancy in pleural fluids. Cytopathol. 2011;22(3):179\u201383.","journal-title":"Cytopathol"},{"issue":"9","key":"1241_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/cncy.21452","volume":"122","author":"LM Rooper","year":"2014","unstructured":"Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol. 2014;122(9):657\u201365.","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"1241_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.6004\/jnccn.2004.0050","volume":"2","author":"JT Cox","year":"2004","unstructured":"Cox JT. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice. J Natl Compr Canc Netw. 2004;2(6):597\u2013611.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7609","key":"1241_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","volume":"335","author":"G Ronco","year":"2007","unstructured":"Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ. 2007;335(7609):28.","journal-title":"BMJ"},{"issue":"5","key":"1241_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3904\/kjim.2016.173","volume":"33","author":"MH Yeon","year":"2018","unstructured":"Yeon MH, Jeong HS, Lee HS, Jang JS, Lee S, Yoon SM, et al. Comparison of liquid-based cytology (CellPrepPlus) and conventional smears in pancreaticobiliary disease. Korean J Intern Med. 2018;33(5):883\u201392.","journal-title":"Korean J Intern Med"},{"issue":"5","key":"1241_CR23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/dc.21199","volume":"38","author":"JA Halford","year":"2010","unstructured":"Halford JA, Batty T, Boost T, Duhig J, Hall J, Lee C, et al. Comparison of the sensitivity of conventional cytology and the ThinPrep Imaging System for 1,083 biopsy confirmed high-grade squamous lesions. Diagn Cytopathol. 2010;38(5):318\u201326.","journal-title":"Diagn Cytopathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01241-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01241-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01241-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T02:52:32Z","timestamp":1700794352000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01241-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01241-4","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patient samples and clinical data using were approved by the Ethics committee of the Peking University Cancer Hospital and the exemption from informed consent was approved as well.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}